BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7597000)

  • 1. Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits: in vitro studies.
    Homsy W; Lefebvre M; Caillé G; du Souich P
    Pharm Res; 1995 Apr; 12(4):609-14. PubMed ID: 7597000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deacetylation of diltiazem by several rabbit tissues.
    Fraile LJ; Aramayona JJ; Bregante MA; García MA; Abadía AR
    Pharm Res; 1996 Dec; 13(12):1875-80. PubMed ID: 8987088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered diltiazem metabolism in the neonatal rabbit following intra-uterine chronic exposure to diltiazem.
    Fraile LJ; Bregante MA; Garcia MA; Solans C
    Xenobiotica; 2001 Apr; 31(4):177-85. PubMed ID: 11465404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-specific pattern of inhibition of diltiazem metabolism at steady state in rabbits.
    Lefebvre M; Caillé G; du Souich P
    J Pharmacol Exp Ther; 1996 Nov; 279(2):902-7. PubMed ID: 8930198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of diltiazem deacetylase and demethylase activities during ontogeny in rabbit.
    Fraile LJ; Bregante MA; Garcia MA; Solans C
    Xenobiotica; 2001 Jul; 31(7):409-22. PubMed ID: 11531005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
    Sutton D; Butler AM; Nadin L; Murray M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits, and rats.
    Yeung PK; Mosher SJ; Quilliam MA; Montague TJ
    Drug Metab Dispos; 1990; 18(6):1055-9. PubMed ID: 1981512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit.
    Homsy W; Caillé G; du Souich P
    Pharm Res; 1995 Nov; 12(11):1722-6. PubMed ID: 8592676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced inhibition of microsomal cytochrome P450 3A2 in rat liver during diltiazem biotransformation.
    Murray M; Butler AM
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1447-52. PubMed ID: 8968370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced diltiazem deacetylase activity in pre-term and full-term rabbits compared with adult rabbits.
    Fraile LJ; Aramayona JJ; Bregante MA; García MA; Solans C
    Biol Neonate; 1997; 72(1):51-61. PubMed ID: 9313835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure.
    Lee YH; Lee MH; Shim CK
    Pharm Res; 1992 Dec; 9(12):1599-606. PubMed ID: 1488404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration.
    Yeung PK; Mosher SJ; Pollak PT
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):69-74. PubMed ID: 1936064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose.
    Yeung PK; Prescott C; Haddad C; Montague TJ; McGregor C; Quilliam MA; Xei M; Li R; Farmer P; Klassen GA
    Eur J Drug Metab Pharmacokinet; 1993; 18(2):199-206. PubMed ID: 8243504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of diltiazem and its metabolites in plasma during storage.
    Yeung PK; Mosher SJ; Klassen GA; McGilveray IJ
    Ther Drug Monit; 1991 Jul; 13(4):369-74. PubMed ID: 1780972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem blood pharmacokinetics in the pregnant and non-pregnant rabbit: maternal and foetal tissue levels.
    Bregante MA; Aramayona JJ; Fraile LJ; Garcia MA; Solans C
    Xenobiotica; 2000 Aug; 30(8):831-41. PubMed ID: 11037114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of diltiazem and its major metabolite, deacetyidiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits.
    Choi JS; Lee JH; Burm JP
    Arch Pharm Res; 2001 Aug; 24(4):333-7. PubMed ID: 11534767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive metabolism of diltiazem and P-glycoprotein-mediated efflux of desacetyl-diltiazem (M1) by rat jejunum in vitro.
    Molden E; Christensen H; Sund RB
    Drug Metab Dispos; 2000 Feb; 28(2):107-9. PubMed ID: 10640504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.
    Zhang X; Quinney SK; Gorski JC; Jones DR; Hall SD
    Drug Metab Dispos; 2009 Aug; 37(8):1587-97. PubMed ID: 19420129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic changes of diltiazem and desacetyldiltiazem after oral administration of diltiazem in rabbits with diabetes mellitus induced by alloxan.
    Choi JS; Kim YG
    Biopharm Drug Dispos; 2002 Apr; 23(3):115-20. PubMed ID: 12173546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of diltiazem in patients with liver cirrhosis.
    Kurosawa S; Kurosawa N; Owada E; Soeda H; Ito K
    Int J Clin Pharmacol Res; 1990; 10(6):311-8. PubMed ID: 2099357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.